J. Grau

发表

Detection of circulating neoplastic cells by reverse-transcriptase polymerase chain reaction in malignant melanoma: association with clinical stage and prognosis.

D. Colomer, B. Mellado, E. Carballo, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Serum Protein S-100 Predicts Clinical Outcome in Patients with Melanoma Treated with Adjuvant Interferon – Comparison with Tyrosinase RT-PCR

J. Malvehy, S. Puig, B. Mellado, 2005, Oncology.

TAG-72, CA 19.9 and CEA as tumor markers in gastric cancer.

L. Grande, J. Fuster, J. García-Valdecasas, 1994, Acta oncologica.

Adjuvant treatment in stage I and II malignant melanoma: a randomized trial between chemoimmunotherapy and immunotherapy.

N. Viñolas, J. Palou, A. Vilalta, 1991, Dermatologica.

Use of CA 19-9 in the early detection of recurrences in colorectal cancer: comparison with CEA.

J. Piqué, X. Filella, A. Ballesta, 1994, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

CEA as a prognostic factor in colorectal cancer.

R. Molina, J. García-Valdecasas, J. Bordas, 1994, Anticancer research.

Mucin-Like Carcinoma-Associated Antigen (MCA) in Tissue and Serum of Patients with Breast Cancer: Clinical Applications in Prognosis and Disease Monitoring

R. Molina, X. Filella, A. Biete, 1993, The International journal of biological markers.

Prognostic value of CA 19.9 levels in colorectal cancer.

E. Campo, J. García-Valdecasas, R. Molina, 1992, Annals of surgery.

Randomized trial of adjuvant chemotherapy with mitomycin plus ftorafur versus mitomycin alone in resected locally advanced gastric cancer.

L. Grande, J. Visa, J. Fuster, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancer.

C. García-Girón, R. Hitt, C. Jara-Sánchez, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of unresectable head and neck cancer.

C. García-Girón, R. Hitt, C. Jara-Sánchez, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Tumor markers in response monitoring and prognosis of non-small cell lung cancer: preliminary report.

N. Viñolas, R. Molina, X. Filella, 1998, Anticancer research.

Chronic oral etoposide in non-small cell lung carcinoma.

C. Agustí, N. Viñolas, J. Ramírez, 1992, European journal of cancer.

Phase II study of combination cetuximab and weekly paclitaxel in patients with metastatic/recurrent squamous cell carcinoma of head and neck (SCCHN): Spanish Head and Neck Cancer Group (TTCC)

M. Hidalgo, R. Hitt, C. Jara, 2007 .

Randomized phase II/III clinical trial of induction chemotherapy (ICT) with either cisplatin/5-fluorouracil (PF) or docetaxel/cisplatin/5-fluorouracil (TPF) followed by chemoradiotherapy (CRT) vs. crt alone for patients (pts) with unresectable locally advanced head and neck cancer (LAHNC).

C. García-Girón, R. Hitt, H. Cortés-Funes, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.